Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ATLANTA, Aug. 19, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat serious and potentially life-threatening infectious diseases, today announced changes to its Board of Directors, including the resignation of Dr. Jeffrey Errington, and the appointment of Mr. John P. Richard to fill the vacancy created by Dr. Errington's resignation.
Help employers find you! Check out all the jobs and post your resume.
ATLANTA, Aug. 19, 2013 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company"), a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat serious and potentially life-threatening infectious diseases, today announced changes to its Board of Directors, including the resignation of Dr. Jeffrey Errington, and the appointment of Mr. John P. Richard to fill the vacancy created by Dr. Errington's resignation.
Help employers find you! Check out all the jobs and post your resume.
